Melanoma and Skin Cancer Center Research Program

The basic research component of the Center serves as the hub providing a continuous source of new targets, biomarkers, therapeutic agents and translation of these discoveries into clinical protocols or trials to benefit melanoma patients. This is accomplished by the program through interactions with faculty throughout the Cancer Institute and scientific community.

It involves identification and validation of novel therapeutic targets, discovery & development of new treatments and clinical evaluation of these experimental drugs in patients thereby providing a constant stream of new agents with improved clinical promise to treat this deadly disease.